CAMBRIDGE, MA, April 23, 2025 /24-7PressRelease/ -- Aditya Humad has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Mr. Humad is a distinguished professional in the health care investment sector and currently serves as the co-founder and chief financial officer of KIC Ventures LLC. Since 2009, he has been instrumental in shaping the company's strategic direction alongside founder & CEO, Dr. Kingsley Chin, who he has known personally for over 20 years after initially meeting at the University of Pennsylvania to review an innovative design concept for spinal disc replacement. His role today encompasses a comprehensive oversight of operations, ensuring he remains informed about all aspects of the business. He collaborates closely with Dr. Chin to develop and execute strategies, analyzing the company's structure from legal, financial and operational perspectives. Mr. Humad also works intimately with supply chain, product development and research teams while engaging with customers and investors.

In addition to his leadership role at KIC Ventures, Mr. Humad is also president of the KIC Management Group, which manages the KIC Ventures' portfolio of majority- or wholly-owned health care companies. This structure allows for centralized operations, enabling shared services across accounting, finance, legal, HR, IT and marketing functions. Through this efficient operating model, the companies are focused on value creation through innovation which has helped over 100,000 patients worldwide improve their quality of life. His strategic insights, combined with the operational synergy of the group, have positioned KIC Ventures to scale health care innovation globally seeking strategic partnerships while remaining agile and self-funded.

Before his tenure at KIC Ventures, Mr. Humad honed his expertise in health care investment banking at JP Morgan Chase & Co. from 2007 to 2009. This experience provided him with invaluable exposure to Wall Street's fast-paced environment, equipping him with the skills necessary to navigate complex financial landscapes. Prior to this role, he served as a research analyst at Wharton Business School from 2005 to 2007, where he developed a strong foundation in financial analysis and research methodologies.

Mr. Humad's educational background includes a dual undergraduate degree in 2007, earning a Bachelors in Biomedical Engineering from the University of Pennsylvania and a Bachelors in Finance from The Wharton School. Additionally, he was selected in the prestigious Jerome Fisher Program in Management and Technology at the University of Pennsylvania, which provided him with a unique blend of engineering and business foundations. In 2021, Mr. Humad further enhanced his leadership development through executive education at Harvard Business School.

Throughout his career, Mr. Humad has demonstrated resilience and adaptability in the evolving health care industry navigating existential challenges including the pandemic, legal matters and capital needs while advancing innovation. His ability to view challenges as opportunities for growth has been pivotal in KIC Ventures' success over the past decade. Despite operating without traditional venture capital backing, Mr. Humad's grit and determination have enabled the company to thrive through reinvesting revenues and project financing with private investors and tight strategic management.

Beyond his professional accomplishments, Mr. Humad is driven by a commitment to improving health care outcomes and access globally. He is involved with the LES Society in Florida in 2008, a nonprofit organization dedicated to advancing Less Exposure Surgery techniques and clinical research for back pain treatment. Mr. Humad has had the opportunity to be involved in mission trips with doctors in Ethiopia allowing him to witness firsthand the impact of their technologies to help children with scoliosis and spine problems.

KIC Venture's focus on innovation has been recognized with AxioMed, one of its key portfolio companies with accolades such as the Global Recognition Award for spinal disc replacement innovation, in 2024. His belief in supporting and investing in innovation alongside Dr. Chin has led to over 50 patents and over 100 clinical publications on their groundbreaking work and innovative technologies.

Looking ahead, Mr. Humad envisions expanding KIC Ventures as a leading investment firm for medical technologies globally to help over 1,000,000 patients soon. He is focused on meeting like-minded individual investors and families that want to invest in advancing spine care and innovations to enhance people's lives worldwide while also building long-term wealth. Through these efforts, Mr. Humad aims to continue driving forward-thinking solutions that address pressing health care challenges on an international scale.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #